Drug resistance – criteria for identifying antimicrobial medicines reserved for treating humans
Summary
A coalition of medical, environmental, and animal protection organisations is calling on the EU's ENVI Committee to strengthen a delegated act to ban the use of Highest Priority Critically Important Antimicrobials (HP CIA) in food-producing animals. The authors argue that these medicines are essential for treating serious human infections, such as cystic fibrosis, and that their use in livestock accelerates the spread of antimicrobial resistance to humans and the environment. They specifically criticise 'Criterion C' of the draft act as a loophole and point to Denmark as an example where such bans have not compromised animal health.
Key insights
- The coalition urges the ENVI Committee to reserve Highest Priority Critically Important Antimicrobials (HP CIA)—which comprise five classes of antimicrobials—exclusively for human medical treatment to prevent their efficacy from being compromised by use in food-producing animals.
- Antimicrobial resistance to HP CIA is already spreading rapidly from animal husbandry to humans and the environment, with poultry meat specifically identified as being contaminated with resistant pathogens.
- The authors argue that 'Criterion C' in the European Commission's draft delegated act creates a dangerous loophole because it allows antimicrobials to be used in animals if they are considered 'essential for animal health', which the authors claim ignores the superior importance of HP CIA for human health.
- The document asserts that HP CIAs are not necessary in livestock farming, citing Denmark as an example where fluoroquinolones and third/fourth generation cephalosporins are virtually unused, and colistin has not been used since 2017, without animal health deteriorating.
- To reduce antimicrobial use, the coalition recommends implementing mandatory antibiotic susceptibility tests prior to use and improving animal breeding, keeping, and feeding conditions.
Cite the original document
- APA
- Germanwatch (2021). Drug resistance – criteria for identifying antimicrobial medicines reserved for treating humans. https://www.germanwatch.org/sites/default/files/Antimicrobials%20reserved%20for%20treating%20humans%20-%20joint%20letter%20from%20organisations%20to%20the%20ENVI%20Committee_July%202021_0.pdf
- Chicago
- Germanwatch. Drug resistance – criteria for identifying antimicrobial medicines reserved for treating humans. 2021. https://www.germanwatch.org/sites/default/files/Antimicrobials%20reserved%20for%20treating%20humans%20-%20joint%20letter%20from%20organisations%20to%20the%20ENVI%20Committee_July%202021_0.pdf.
- Wikipedia
- {{cite press release |author=Germanwatch |title=Drug resistance – criteria for identifying antimicrobial medicines reserved for treating humans |date=6 July 2021 |url=https://www.germanwatch.org/sites/default/files/Antimicrobials%20reserved%20for%20treating%20humans%20-%20joint%20letter%20from%20organisations%20to%20the%20ENVI%20Committee_July%202021_0.pdf |access-date=5 November 2026 |via=Climate Insights Directory (document gerwat-001419)}}
- BibTeX
- @misc{germanwatch2021drug, author = {{Germanwatch}}, title = {{Drug resistance – criteria for identifying antimicrobial medicines reserved for treating humans}}, publisher = {Germanwatch}, year = {2021}, month = jul, url = {https://www.germanwatch.org/sites/default/files/Antimicrobials%20reserved%20for%20treating%20humans%20-%20joint%20letter%20from%20organisations%20to%20the%20ENVI%20Committee_July%202021_0.pdf}, urldate = {2026-11-05}, note = {Indexed by Climate Insights Directory, document gerwat-001419} }
Full text
Collected · Record updated